SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-032929
Filing Date
2021-02-09
Accepted
2021-02-08 21:55:33
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d102691ds3.htm S-3 487599
2 EX-1.2 d102691dex12.htm EX-1.2 240252
3 EX-5.1 d102691dex51.htm EX-5.1 30162
4 EX-5.2 d102691dex52.htm EX-5.2 5018
5 EX-23.1 d102691dex231.htm EX-23.1 1569
6 GRAPHIC g102691g0208151843471.jpg GRAPHIC 6030
7 GRAPHIC g102691g15u63.jpg GRAPHIC 39208
  Complete submission text file 0001193125-21-032929.txt   821304
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252873 | Film No.: 21603716
SIC: 2834 Pharmaceutical Preparations